Advocates for Community Health (ACH) was featured in 340B Report following the release of Senator Bill Cassidy’s discussion draft proposing significant changes to the 340B Drug Pricing Program.
In the article, ACH Senior Vice President of Policy and Government Affairs Stephanie Krenrich emphasized ACH’s longstanding support for thoughtful 340B reform while expressing concerns that the proposal would weaken community health centers at a time when they are facing unprecedented challenges.
“Our vision of reform is centered around support for community health centers and strengthening a federal program that can be a lifeline to rural and underserved patients across America. Unfortunately, Sen. Cassidy’s proposal does not align with our core principles for reform. In a moment where health centers are facing unprecedented challenges, his proposal further weakens the country’s primary care safety net.”
The article examines reactions from national provider organizations, hospitals, community health centers, and the pharmaceutical industry to the discussion draft, which includes proposed changes to rebates, contract pharmacies, patient definitions, reporting requirements, and other aspects of the 340B program.